Search
Search Results
##search.searchResults.foundPlural##
-
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
2268PDF: 751HTML: 2144Untitled: 245Untitled: 170Untitled: 200Untitled: 173Untitled: 191Untitled: 200Untitled: 204 -
ZYGOMYCOSIS IN IMMUNOCOMPROMISED NON-HAEMATOLOGICAL PATIENTS
2985PDF: 997HTML: 7496 -
EFFICACY AND SAFETY OF SINOPHARM VACCINE FOR SARS-COV-2 AND BREAKTHROUGH INFECTIONS IN IRANIAN PATIENTS WITH HEMOGLOBINOPATHIES: A PRELIMINARY REPORT Sinopharm Vaccination in Iranian Patients with Hemoglobinopathies
1767PDF: 763HTML: 238 -
BACTERIAL INFECTIONS IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
3306PDF: 1900HTML: 3692 -
END-OF-LIFE CARE IN SICKLE CELL DISEASE AND TRASFUSION DEPENDEND-β-THALASSEMIA: CLINICAL, PSYCHOLOGICAL, AND ETHICAL CONSIDERATION Challenges in Supportive Care, Equity, and Compassion at End of Life
1197PDF: 847Html: 192 -
DIAGNOSTIC VALUE OF BRONCHOALVEOLAR LAVAGE IN LEUKEMIC AND BONE MARROW TRANSPLANT PATIENTS: THE IMPACT OF ANTIMICROBIAL THERAPY
2025PDF: 843HTML: 2212Table 1: 203Table 2: 218Table 3: 217Table 4: 219Table 5: 214Tble 6: 209Cover Letter: 228Greene Tab.7: 227 -
GLUCOSE HOMEOSTASIS AND ΑSSESSMENT OF Β-CELL FUNCTION BY 3-HOUR ORAL GLUCOSE TOLERANCE (OGTT) IN PATIENTS WITH Β-THALASSEMIA MAJOR WITH SERUM FERRITIN BELOW 1,000 NG/DL: RESULTS FROM A SINGLE ICET-A CENTRE OGTT in thalassemia and iron overload
4029PDF: 1169HTML: 466 -
CLINICAL AND LABORATORY FEATURES OF SICKLE CELL DISEASE S/D PUNJAB: IMPACT OF HBF AND HYDROXYUREA SCD S/D Punjab
1394PDF: 1200HTML: 137 -
DISTRIBUTION OF DNA DAMAGE REPAIR GENE POLYMORPHISM hOGG1, XRCC1 and p53 AMONG SICKLE CELL DISEASE PATIENTS IN INDIA
1610PDF: 815HTML: 1529Table Genotype and allele frequencies of hOGG1 codon 326 Ser>Cys and p53 72Arg>Pro polymorphisms among SCD patients and control group: 197 -
Coronavirus disease 2019 (COVID-19) severity in patients with thalassemias: A Nationwide Iranian Experience Coronavirus in patients with thalassemias
1477PDF: 519HTML: 190 -
-
CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
1591PDF: 921HTML: 1016figures: 211table 1: 207table2: 207table3: 211 -
HOW I TREAT NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA
13331PDF: 1012HTML: 7311 -
NOVEL MUTATIONS IN THE NON-STRUCTURE PROTEIN 2 OF SARS-CoV-2 Sequence analysis NSP2 of SARS-CoV-2
1068PDF: 496HTML: 143 -
THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA
2555PDF: 820HTML: 1745 -
MALARIA AND HIV IN ADULTS: When The Parasite runs into The Virus
2765PDF: 1043HTML: 2390 -
How I treat acute and persistent sickle cell pain
2050PDF: 1153HTML: 673 -
MONITORING THE RESPONSE TO TYROSINE KINASE INHIBITOR (TKI) TREATMENT IN CHRONIC MYELOID LEUKEMIA (CML)
4114PDF: 1575HTML: 9278Untitled: 306Untitled: 203Untitled: 190Untitled: 187Untitled: 204Untitled: 362 -
PATIENTS WITH HAEMOGLOBINOPATHIES AND CHRONIC HEPATITIS C: A REALLY DIFFICULT TO TREAT POPULATION IN 2016?
2992PDF: 1011HTML: 2114Cover letter: 197 -
PROCALCITONIN AS A BIOMARKER OF BACTERIAL INFECTION IN SICKLE CELL VASO-OCCLUSIVE CRISIS.
2131PDF: 1086HTML: 15735COVER LETTER: 210 -
NUTRITIONALLY VARIANT STREPTOCOCCI BACTEREMIA IN CANCER PATIENTS: A RETROSPECTIVE STUDY, 1999-2014
2217PDF: 1035HTML: 4092Cover Letter: 241Figure 1: 255Figure 2: 248Table 1: 229 -
-
Takayasu Arteritis Initially Mimicking Infective Endocarditis
1347PDF: 624HTML: 1113 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
4277Suppl. Files: 1212PDF: 1126Html: 256 -
TREATMENT OF CANCER IN THE OLDER AGED PERSON
1233PDF: 863HTML: 3416







